Talat Bessissow
Montreal, QC H4A3J1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 183 publications
IBD and Immune-Mediated Inflammatory Diseases: What Is the Optimal Management?
Journal: Journal of clinical medicine
Published: May 13, 2026
Communicating Needs and Features of IBD Experiences study: Canadian individuals and healthcare professional perceptions of the experience and impact of symptoms of moderate-to-severe ulcerative colitis and Crohn's disease.
Journal: Journal of the Canadian Association of Gastroenterology
Published: February 11, 2026
The Association of Faecal Calprotectin Measurements With Endo-Histological Remission in Ulcerative Colitis: A Pooled Analysis.
Journal: Alimentary pharmacology & therapeutics
Published: January 05, 2026
Practices and perceptions of advanced endoscopic imaging techniques for colorectal neoplasia detection in patients with inflammatory bowel disease: report of a survey among Canadian inflammatory bowel disease specialists.
Journal: iGIE : innovation, investigation and insights
Published: November 12, 2025
Successful Treatment of Refractory Pruritus in Primary Sclerosing Cholangitis with Upadacitinib: A Case Report.
Journal: Case reports in gastroenterology
Published: October 29, 2025
Pharmacological management of upper gastrointestinal Crohn's disease: a systematic review.
Journal: Journal of Crohn's & colitis
Published: October 28, 2025
Closing the Middle East and north Africa representation gap in clinical trials in inflammatory bowel disease.
Journal: The lancet. Gastroenterology & hepatology
Published: October 21, 2025
Rare Rectal Involvement of Metastatic Appendiceal Adenocarcinoma Mimicking Primary Rectal Cancer.
Journal: ACG case reports journal
Published: October 07, 2025
Effects of Ultra-Processed Foods and Food Additives on Disease Activity in Adults with Inflammatory Bowel Disease: A Scoping Review.
Journal: Journal of clinical medicine
Published: September 20, 2025
Clinical outcomes and drug sustainability after non-medical switch from ustekinumab originator to biosimilars in inflammatory bowel disease.
Journal: World journal of gastroenterology
Published: September 17, 2025
Last Updated: 09/26/2026